Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleophilic Substitution and Catalytic Hydrogenolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111978320B reveals a high-yield two-step route for renin inhibitor intermediates, offering significant cost reduction in API manufacturing and scalable production.
Patent CN102093292A reveals a safe two-step route for DL-alpha-aminocaprolactam, eliminating toxic azides for reliable pharmaceutical intermediates manufacturing.